{"id":5980,"date":"2022-12-22T08:07:30","date_gmt":"2022-12-22T16:07:30","guid":{"rendered":"https:\/\/allocare.caredx.com\/?p=5980"},"modified":"2022-12-22T08:07:41","modified_gmt":"2022-12-22T16:07:41","slug":"new-ishlt-guidelines-support-use-of-caredxs-heartcare-solutions-allomap-and-allosure-in-routine-monitoring-of-heart-transplant-patients","status":"publish","type":"post","link":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/indexphp\/post\/2022\/12\/22\/new-ishlt-guidelines-support-use-of-caredxs-heartcare-solutions-allomap-and-allosure-in-routine-monitoring-of-heart-transplant-patients\/","title":{"rendered":"New ISHLT Guidelines Support Use of CareDx\u2019s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients"},"content":{"rendered":"<span class=\"simplefavorite-button has-count loading\" data-postid=\"5980\" data-siteid=\"1\" data-groupid=\"1\" data-favoritecount=\"0\" style=\"\">Loading<span class=\"sf-icon-spinner-wrapper\"><i class=\"sf-icon-spinner\"><\/i><\/span><\/span>\n<p>DECEMBER, 21, 2022<\/p>\n\n\n\n<p><em>ISHLT Guidelines Recommend Earlier Use of AlloMap Heart Starting 2 Months Post-Transplant Based on Strength of Clinical Studies<\/em><\/p>\n\n\n\n<p><em>ISHLT Guidelines Recommend Remote Use of GEP and dd-cfDNA Heart Transplant Surveillance, as in HeartCare, May be Used to Reduce the Need for Biopsies and Hospital Visits<\/em><\/p>\n\n\n\n<p>BRISBANE, Calif.&#8211;(BUSINESS WIRE)&#8211;\u00a0CareDx, Inc. (Nasdaq: CDNA) \u2013 The Transplant Company\u2122 focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers \u2013 today announced the publication<sup>1<\/sup>\u00a0of new guidelines by the International Society for Heart and Lung Transplantation (ISHLT) supporting the use of CareDx\u2019s non-invasive molecular surveillance portfolio. <a href=\"https:\/\/investors.caredx.com\/news\/news-details\/2022\/New-ISHLT-Guidelines-Support-Use-of-CareDxs-HeartCare-Solutions-AlloMap-and-AlloSure-in-Routine-Monitoring-of-Heart-Transplant-Patients\/default.aspx\">Read the complete press release<\/a> on CareDx.com.<\/p>\n<span class=\"simplefavorite-button has-count loading\" data-postid=\"5980\" data-siteid=\"1\" data-groupid=\"1\" data-favoritecount=\"0\" style=\"\">Loading<span class=\"sf-icon-spinner-wrapper\"><i class=\"sf-icon-spinner\"><\/i><\/span><\/span>","protected":false},"excerpt":{"rendered":"<p>Loading DECEMBER, 21, 2022 ISHLT Guidelines Recommend Earlier Use of AlloMap Heart Starting 2 Months Post-Transplant Based on Strength of Clinical Studies ISHLT Guidelines Recommend Remote Use of GEP and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/indexphp\/post\/2022\/12\/22\/new-ishlt-guidelines-support-use-of-caredxs-heartcare-solutions-allomap-and-allosure-in-routine-monitoring-of-heart-transplant-patients\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;New ISHLT Guidelines Support Use of CareDx\u2019s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients&#8221;<\/span><\/a><\/p>\n","protected":false},"author":208,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":0,"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_tribe_blocks_recurrence_rules":"","_tribe_blocks_recurrence_description":"","_tribe_blocks_recurrence_exclusions":"","_ecp_custom_2":"","footnotes":""},"categories":[5,344],"tags":[66,1452],"post_format":[],"Dislikes":"","Likes":"","simplefavorites_count":"","views":"1252","post_likes_plusCounter":"2","post_dislikes_plusCounter":"","acf":[],"_links":{"self":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/5980"}],"collection":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/users\/208"}],"replies":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/comments?post=5980"}],"version-history":[{"count":1,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/5980\/revisions"}],"predecessor-version":[{"id":5982,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/5980\/revisions\/5982"}],"wp:attachment":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/media?parent=5980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/categories?post=5980"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/tags?post=5980"},{"taxonomy":"post_format","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/post_format?post=5980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}